Mario Crovetto
Chief Executive Officer bij IKONISYS S.A.
Vermogen: 1 043 $ op 31-03-2024
Profiel
Mario P.
Crovetto is currently the Chief Executive Officer & Director at Ikonisys SA. He is also a Member-Supervisory Board at Curetis GmbH.
Previously, he served as an Independent Director at OpGen, Inc. from 2020 to 2024.
Prior to that, he was the Chief Financial Officer at Eurand NV from 1999 to 2011 and the CFO & Vice President-Corporate Development at Recordati SpA from 1990 to 1999.
He also served as an Independent Member-Supervisory Board at Curetis NV from 2015 to 2020.
Mr. Crovetto holds a graduate degree from Harvard University and an undergraduate degree from Università Cattolica del Sacro Cuore Campus di Milano.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
OPGEN, INC.
0.01% | 30-06-2023 | 1 500 ( 0.01% ) | 1 043 $ | 31-03-2024 |
Actieve functies van Mario Crovetto
| Bedrijven | Functie | Begin |
|---|---|---|
| IKONISYS S.A. | Chief Executive Officer | 01-07-2021 |
Curetis GmbH
 Curetis GmbH Medical SpecialtiesHealth Technology Curetis GmbH operates as a molecular diagnostics company which focuses on the development and commercialization of products for diagnosing severe infectious diseases. The firm offers diagnostic solutions for hospitals and large-scale laboratories. Its products include Unyvero L4 Lysator, Unyvero C8 Cockpit, Unyvero A50 Analyzer, and Unyvero Application Cartridges. The company was founded by Andreas Boos, Johannes Bacher, Gerd Lüdke, and Anne Thews in August 2007 and is headquartered in Holzgerlingen, Germany. | Director/Board Member | - |
Eerdere bekende functies van Mario Crovetto
| Bedrijven | Functie | Einde |
|---|---|---|
| OPGEN, INC. | Director/Board Member | 25-03-2024 |
| CURETIS N.V. | Director/Board Member | 01-04-2020 |
Eurand NV
 Eurand NV Pharmaceuticals: MajorHealth Technology Eurand NV develops pharmaceutical and biopharmaceutical products using proprietary drug formulation technologies. The company was founded in 1984 and is headquartered in Amsterdam, the Netherlands. | Director of Finance/CFO | 01-01-2011 |
| RECORDATI | Director of Finance/CFO | 01-01-1999 |
Opleiding van Mario Crovetto
| Harvard University | Graduate Degree |
| Università Cattolica del Sacro Cuore Campus di Milano | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| OPGEN, INC. | Commercial Services |
| RECORDATI | Health Technology |
| IKONISYS S.A. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Eurand NV
Eurand NV Pharmaceuticals: MajorHealth Technology Eurand NV develops pharmaceutical and biopharmaceutical products using proprietary drug formulation technologies. The company was founded in 1984 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
Curetis GmbH
Curetis GmbH Medical SpecialtiesHealth Technology Curetis GmbH operates as a molecular diagnostics company which focuses on the development and commercialization of products for diagnosing severe infectious diseases. The firm offers diagnostic solutions for hospitals and large-scale laboratories. Its products include Unyvero L4 Lysator, Unyvero C8 Cockpit, Unyvero A50 Analyzer, and Unyvero Application Cartridges. The company was founded by Andreas Boos, Johannes Bacher, Gerd Lüdke, and Anne Thews in August 2007 and is headquartered in Holzgerlingen, Germany. | Health Technology |
Curetis NV
 Curetis NV Medical/Nursing ServicesHealth Services Curetis NV engages in the manufacture, research and development, and commercialization of molecular microbiology solutions. It offers unyvero platform, which comprsises of the unyvero system with the A50 analyzer at its core, proprietary software, and single-use, application-specific cartridges. The company was founded by Johannes Bacher, Gerd Luedke and Andreas Boos in August 2007 and is headquartered in Holzgerlingen, Germany. | Health Services |
